BiotechTube
Home/Astellas Pharma/Masao Yoshida
MY

Masao Yoshida

Executive Vice President

Astellas Pharma

Therapeutic Areas

UrologyOncologyImmunologyNeuroscienceNephrology

Astellas Pharma Pipeline

DrugIndicationPhase
Xtandi (enzalutamide)Prostate CancerApproved
Betmiga (mirabegron)Overactive BladderApproved
Prograf (tacrolimus)ImmunosuppressionApproved
Vesicare (solifenacin)Overactive BladderApproved
ASP2215 (gilteritinib)Acute Myeloid LeukemiaApproved
ASP1929Solid TumorsPhase 2
ASP0367Urothelial CarcinomaPhase 3
ASP3652NASHPhase 2

Leadership Team at Astellas Pharma

KY
Kenji Yasukawa
President and Chief Executive Officer
TT
Tadaaki Taniguchi
Executive Vice President and Chief Financial Officer
YS
Yoshitsugu Shitaka
Senior Vice President, Chief Medical Officer
TA
Takeshi Aramaki
Senior Vice President, Head of Development
AP
Adam Pearson
Senior Vice President, Head of Oncology Development
View full Astellas Pharma profile